Serum interleukin-17 & nitric oxide levels in patients with primary Sjögren's syndrome.

about

Serum interleukin 17 levels in patients with Crohn's disease: real life data.Vitamin D deficiency and lower TGF-β/IL-17 ratio in a North Indian cohort of pemphigus vulgaris.T Cell-Associated Cytokines in the Pathogenesis of Sjögren's Syndrome

P2860

Q30843734-C549A395-37F3-422C-B50A-52FF0A6ECA1A Q34581940-580AD0AE-EEBA-4FD1-AA7D-2DACC258DEE2 Q36957148-F4C0AB23-631B-4F5C-92C0-6A9654C8F52C

P2860

Serum interleukin-17 & nitric oxide levels in patients with primary Sjögren's syndrome.

Item

http://www.wikidata.org/entity/Q36064302

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Serum interleukin-17 & nitric oxide levels in patients with primary Sjögren's syndrome.

@ast

Serum interleukin-17 & nitric oxide levels in patients with primary Sjögren's syndrome.

@en

type

Item

label

Serum interleukin-17 & nitric oxide levels in patients with primary Sjögren's syndrome.

@ast

Serum interleukin-17 & nitric oxide levels in patients with primary Sjögren's syndrome.

@en

prefLabel

Serum interleukin-17 & nitric oxide levels in patients with primary Sjögren's syndrome.

@ast

Serum interleukin-17 & nitric oxide levels in patients with primary Sjögren's syndrome.

@en

P1476

Serum interleukin-17 & nitric oxide levels in patients with primary Sjögren's syndrome

@en

P2093

D Bugarski

http://www.w3.org/2001/XMLSchema#string

M Miletic

http://www.w3.org/2001/XMLSchema#string

O Pajic

http://www.w3.org/2001/XMLSchema#string

P Milenkovic

http://www.w3.org/2001/XMLSchema#string

R Stojanovic

http://www.w3.org/2001/XMLSchema#string

S Mojsilovic

http://www.w3.org/2001/XMLSchema#string

P2860

Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis

The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis

A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage

Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjögren's Syndrome.

Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells.

IL17: potential therapeutic target in Sjögren's syndrome using adenovirus-mediated gene transfer.

Cytokines in Sjogren's syndrome: potential therapeutic targets.

Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity.

Apoptosis and Sjögren syndrome.

Inducible nitric oxide synthase activation by interleukin-17.

P304

513-519

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

135

http://www.w3.org/2001/XMLSchema#string

P50

Vladan P Čokić

P577

2012-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22664499

http://www.w3.org/2001/XMLSchema#string

P932

3385235

http://www.w3.org/2001/XMLSchema#string

Serum interleukin-17 & nitric oxide levels in patients with primary Sjögren's syndrome.

about

P2860

P2860

Serum interleukin-17 & nitric oxide levels in patients with primary Sjögren's syndrome.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P407

P433

P478

P50

P577

P698

P932

P1433

P1476

P2093

P2860

P304

P31

P407

P433

P478

P50

P577

P698

P932